Atara Biotherapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 12/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 12/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0.6 | $0.5 | $3.5 | $18 | $98 | $40 | $29 | $27 | |
| −$4.8 | −$4.1 | −$4.3 | $2.4 | $38 | −$22 | −$19 | −$32 | |
| −$0.32 | −$0.29 | −$0.32 | $0.19 | $3.50 | −$2.93 | −$3.10 | −$5.65 | |
| 15 | 14 | 14 | 12 | 11 | 7.5 | 6.1 | — |
Trend